316 related articles for article (PubMed ID: 25877311)
1. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
2. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
[TBL] [Abstract][Full Text] [Related]
3. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
4. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
5. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
6. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
7. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
8. CCR6
He H; Wu J; Zang M; Wang W; Chang X; Chen X; Wang R; Wu Z; Wang L; Wang D; Lu F; Sun Z; Qu C
Am J Cancer Res; 2017; 7(5):1151-1163. PubMed ID: 28560063
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
10. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
[TBL] [Abstract][Full Text] [Related]
11. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
12. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.
Hirata T; Osuga Y; Takamura M; Kodama A; Hirota Y; Koga K; Yoshino O; Harada M; Takemura Y; Yano T; Taketani Y
Endocrinology; 2010 Nov; 151(11):5468-76. PubMed ID: 20881253
[TBL] [Abstract][Full Text] [Related]
14. [Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].
Wang WW; Wang ZM; Liu YY; Qin YH; Shen Q
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):757-61. PubMed ID: 21163066
[TBL] [Abstract][Full Text] [Related]
15. [The expression and mechanisms of interleukin-17 in CD(8)(+) T cells of mice with cigarette smoke-induced emphysema].
Duan MC; Zhong XN; Huang Y; He ZY; Tang HJ
Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):776-80. PubMed ID: 22176968
[TBL] [Abstract][Full Text] [Related]
16. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro.
Fujii H; Itoh Y; Yamaguchi K; Yamauchi N; Harano Y; Nakajima T; Minami M; Okanoue T
Biochem Biophys Res Commun; 2004 Sep; 322(3):1052-8. PubMed ID: 15336571
[TBL] [Abstract][Full Text] [Related]
17. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
Kim TG; Byamba D; Wu WH; Lee MG
Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.
Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
[TBL] [Abstract][Full Text] [Related]
20. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6.
Tanida S; Yoshitomi H; Nishitani K; Ishikawa M; Kitaori T; Ito H; Nakamura T
Cytokine; 2009 Aug; 47(2):112-8. PubMed ID: 19535263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
